Actuarial firm Milliman completed the study, which analyzed out-of-pocket medical costs for patients with lymphoma, heart attack, lung cancer, diabetes and mental health hospitalizations.
Patients with short-term health plans receiving a new lymphoma diagnosis could face between $23,100 and $45,800 in out-of-pocket expenses, including premiums and cost-sharing, in the six months after diagnosis. In comparison, the same person with an ACA-compliant plan could pay $6,300 on average in out-of-pocket expenses, the study found.
Costs are higher for newly diagnosed lung cancer patients with short-term health plans. Those patients could face more than $100,000 in out-of-pocket expenses in the six months after diagnosis, should the patient be unable to renew their plan and become uninsured.
Read the full report here.
More articles on healthcare finance:
Woman sued by Alabama hospital over $31K bill: ‘I wish you’d have let me die’
HCA reverses decision to close Florida hospital
Kentucky hospital to close in April
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
